Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.

Nurmohamed MT, van der Horst-Bruinsma I, Maksymowych WP.

Curr Rheumatol Rep. 2012 Oct;14(5):415-21. doi: 10.1007/s11926-012-0270-6. Review.

PMID:
22791397
2.

Cardiovascular disease and rheumatoid arthritis: an update.

Charles-Schoeman C.

Curr Rheumatol Rep. 2012 Oct;14(5):455-62. doi: 10.1007/s11926-012-0271-5. Review.

3.

Inflammatory arthritis as a novel risk factor for cardiovascular disease.

John H, Kitas G.

Eur J Intern Med. 2012 Oct;23(7):575-9. doi: 10.1016/j.ejim.2012.06.016. Epub 2012 Jul 28. Review.

PMID:
22841864
4.

Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis.

McCarey D, Sturrock RD.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S124-6.

PMID:
19822058
5.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT.

Ann Rheum Dis. 2010 Feb;69(2):325-31. doi: 10.1136/ard.2009.113696. Epub 2009 Sep 22.

PMID:
19773290
6.

Comorbidities in patients with spondyloarthritis.

van der Horst-Bruinsma IE, Nurmohamed MT, Landewé RB.

Rheum Dis Clin North Am. 2012 Aug;38(3):523-38. doi: 10.1016/j.rdc.2012.08.010. Epub 2012 Sep 14. Review.

PMID:
23083753
7.

Spondyloarthropathies: an independent cardiovascular risk factor?

Mathieu S, Motreff P, Soubrier M.

Joint Bone Spine. 2010 Dec;77(6):542-5. doi: 10.1016/j.jbspin.2010.05.001. Epub 2010 Jun 19. Review.

PMID:
20646947
8.

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

Mathieu S, Gossec L, Dougados M, Soubrier M.

Arthritis Care Res (Hoboken). 2011 Apr;63(4):557-63. doi: 10.1002/acr.20364. Review.

9.

[Risk factors of cardiovascular complications in inflammatory seronegative spondyloarthropathies].

Ozdowska P, Dąbrowski R, Głuszko P, Szwed H.

Kardiol Pol. 2013;71(4):417-20. doi: 10.5603/KP.2013.0073. Review. Polish. No abstract available.

10.

Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis.

Peters MJ, van Eijk IC, Smulders YM, Serne E, Dijkmans BA, van der Horst-Bruinsma IE, Nurmohamed MT.

J Rheumatol. 2010 Jan;37(1):161-6. doi: 10.3899/jrheum.090667. Epub 2009 Dec 1.

PMID:
19955053
11.

Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis.

Bremander A, Petersson IF, Bergman S, Englund M.

Arthritis Care Res (Hoboken). 2011 Apr;63(4):550-6. doi: 10.1002/acr.20408.

12.

Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis.

Hamdi W, Chelli Bouaziz M, Zouch I, Ghannouchi MM, Haouel M, Ladeb MF, Kchir MM.

J Rheumatol. 2012 Feb;39(2):322-6. doi: 10.3899/jrheum.110792. Epub 2012 Jan 15.

PMID:
22247364
13.

The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis.

Dik VK, Peters MJ, Dijkmans PA, Van der Weijden MA, De Vries MK, Dijkmans BA, Van der Horst-Bruinsma IE, Nurmohamed MT.

Scand J Rheumatol. 2010;39(1):38-41. doi: 10.3109/03009740903096101.

PMID:
20132069
14.

[Rheumatic diseases as risk factors for cardiovascular disease].

Nurmohamed MT, Voskuyl AE, van der Horst-Bruinsma IE, Dijkmans BA.

Ned Tijdschr Geneeskd. 2006 Sep 2;150(35):1921-4. Review. Dutch.

PMID:
16999275
15.

Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis.

Azevedo VF, Pecoits-Filho R.

Rheumatol Int. 2010 Sep;30(11):1411-6. doi: 10.1007/s00296-010-1416-3. Epub 2010 Mar 27. Review.

PMID:
20349072
16.

[Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].

Kung M, Störk S, Angermann CE.

Herz. 2005 Sep;30(6):512-21. Review. German.

PMID:
16170682
17.

[Inflammation-related cardiovascular morbidity : Pathophysiology and therapy].

Fischer-Betz R, Halle M, Schneider M.

Z Rheumatol. 2010 Oct;69(8):680-4, 686-8. doi: 10.1007/s00393-009-0585-5. German.

PMID:
20862480
18.

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV.

J Rheumatol. 2006 Nov;33(11):2167-72. Epub 2006 Sep 1.

PMID:
16981296
19.

Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis.

Papagoras C, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):612-20. Epub 2013 Feb 7. Review.

PMID:
23406817
20.

Where the immune response meets the vessel wall.

Bisoendial RJ, Stroes ES, Tak PP.

Neth J Med. 2009 Sep;67(8):328-33. Review.

Items per page

Supplemental Content

Write to the Help Desk